甘肃信谊天森药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
35
NMPA:35
Drug Approvals
Compound Pancreatin Powder
- Product Name
- 复方胰酶散
- Approval Number
- 国药准字H62021209
- Approval Date
- Dec 14, 2023
NMPA
Compound Hepar Extract Tablets
- Product Name
- 复方肝水解物片
- Approval Number
- 国药准字H62021172
- Approval Date
- Dec 14, 2023
NMPA
Compound Hepar Extractum Tablets
- Product Name
- 复方肝浸膏片
- Approval Number
- 国药准字H62021091
- Approval Date
- Dec 14, 2023
NMPA
Compound Hepar Extract Tablets
- Product Name
- 复方肝水解物片
- Approval Number
- 国药准字H62021193
- Approval Date
- Jan 14, 2020
NMPA
Compound Hepar Extractum Capsules
- Product Name
- 复方肝浸膏胶囊
- Approval Number
- 国药准字H62021191
- Approval Date
- Jan 14, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found